Sofinnova Investments, Inc.

Q3 2021 13F Holdings Report, Stock Holdings

Signature - Title
Nathalie Auber - Attorney-in-Fact
Location
Menlo Park, CA
Holdings as of
30 Sep 2021
Value $
$1,559,794,000
Num holdings
61
Filing time
15 Nov 2021, 13:27:06 UTC
Form type
13F-HR
Description
All US holdings of this investor are reported in this report. Top holdings included NTRA, KRTX, ASND, AVTE, and AZN.
Previous filing
Q2 2021 - 16 Aug 2021
Next filing
Q4 2021 - 14 Feb 2022
SEC
View on sec.gov
Options Holdings
Showing stock holdings, see here for options holdings
Sym Weight Trade Impact Company Class Share Change Activity Value Change $ Value $ * Price $ Shares Principal
Filing 2021 Q3 compared to 2021 Q2 by default. Changes are calculated vs the previous SEC filing.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Nathalie Auber Attorney-in-Fact Menlo Park, California 15 Nov 2021

Sofinnova Investments, Inc. is filing this Form 13F on behalf of itself and the general partner entities of the investment funds for which it serves as the investment adviser, Sofinnova Management VII, L.L.C., Sofinnova Management VIII, L.L.C., Sofinnova Management IX, L.L.C., Sofinnova Management X, L.L.C., and Sofinnova BioEquities GP LLC.